# Title

 Food and Drugs. PART 1311â€”REQUIREMENTS FOR ELECTRONIC ORDERS AND PRESCRIPTIONS


# ID

 CFR-2018-title21-vol9.Pt. 1311


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                             |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['at least', 'within', 'less than', 'prior to', 'after', 'minimum', 'more than', 'no later than', 'equal to', 'before']                                                                                            |
| Duration    | ['1 day', '45.0 day', '5 day', '5 minute', '6.0 hour', '2 year', '7 day', '10.0 minute', '24.0 hour']                                                                                                              |
| Condition   | ['when', 'unless', 'subject to', 'as soon as', 'until', 'provided that', 'if', 'where']                                                                                                                            |
| Entities    | ['Pharmacy', 'Eligibility', 'Practitioner', 'Application', 'Electronic', 'Burr, W.et', 'Scope', 'Food', 'Failure', 'Registration', 'Test', 'Internal', 'Veterans Affairs']                                         |
| Date        | ['2018-09-01', '2004-11-04', '2007-01-01', '2002-12-03', '2009-06-01', '2002-08-01', '2005-01-31', '2004-09-23', '2025-02-01', '2008-12-08', '2001-05-25', '2004-02-23', '2005-10-01', '2008-10-01', '2000-01-27'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                                         |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------------------|
| after         | the document have been altered during transmission or after  receipt.                                                                           |
| after         | the applicant with the signed public key certificate. after                                                                                     |
| within        | via a revocation request, to the Certification Authority within 24 hours of substantiation of the loss, theft,                                  |
| before        | a CSOS certificate holder applies for a renewal before the certificate expires, the certificate holder may renew                                |
| before        | (d) If a CSOS certificate expires  before the holder applies for a renewal, the certificate                                                     |
| within        | attorney must report to the DEA Certification Authority within 6 hours of either of the following (advance                                      |
| before        | a digitally signed order must do the following before filling the order: (1) Verify the integrity of                                            |
| after         | system must set a 10-minute inactivity time period after which the certificate holder must reauthenticate the password                          |
| within        | system must have a time system that is within five minutes of the official National Institute of                                                |
| within        | system must have a time system that is within five minutes of the official National Institute of                                                |
| within        | of any other audits of the software completed within  the previous two years.                                                                   |
| within        | notify the individuals designated under &#167;&#8201;1311.125 or &#167;&#8201;1311.130 within one business day of discovery that the hard       |
| before        | for a prescription under &#167;&#8201;1306.05(a) of this chapter. before                                                                        |
| within        | designated under &#167;&#8201;1311.125 or &#167;&#8201;1311.130 and the Administration within one business day of discovery that one or         |
| prior to      | an agent enters information at the practitioner's direction prior to the practitioner reviewing and approving the information and               |
| within        | to sign prescriptions for controlled substances, the entity within a DEA-registered institutional practitioner that grants that individual      |
| within        | issue the authentication credentials to a separate entity within the institutional practitioner or to an outside credential                     |
| at least      | which it is gaining access and must meet at least the criteria of FIPS 140-2 Security Level 1,                                                  |
| at least      | match rate, is tested so that there is at least 95% confidence that the false match and non-match                                               |
| equal to      | that the false match and non-match rates are equal to  or less than the observed value.                                                         |
| less than     | match and non-match rates are equal to or less than  the observed value.                                                                        |
| at least      | following: (i) Link each registrant, by name, to at least  one DEA registration number.                                                         |
| at least      | of registrant unless that individual is linked to at least one DEA registration number as provided in paragraph                                 |
| more than     | (7) If a practitioner has  more than one DEA registration number, the electronic prescription application                                       |
| within        | application must have a time application that is within five minutes of the official National Institute of                                      |
| after         | must not permit alteration of the DEA elements after the practitioner has indicated that a controlled substance                                 |
| more than     | (13) Where a practitioner seeks to prescribe  more than one controlled substance at one time for a                                              |
| at least      | &#167;&#8201;1311.140(a)(4), the electronic prescription application must digitally sign at least the information required by part 1306 of this |
| at least      | by part 1306 of this chapter must be at least  FIPS 140-2 Security Level 1 validated.                                                           |
| after         | information required by part 1306 of this chapter after  the prescription has been digitally signed.                                            |
| after         | information required by part 1306 of this chapter after the prescription is digitally signed must cancel the                                    |
| after         | prescription application must allow printing of a prescription after transmission only if the printed prescription is clearly                   |
| within        | (24) The electronic prescription application must record  within each audit record the following information: (i) The                           |
| no later than | month and provide the log to the practitioner no later than  seven calendar days after that month.                                              |
| after         | the practitioner no later than seven calendar days after  that month.                                                                           |
| at least      | from which to generate the log must span at least  the previous two years.                                                                      |
| at least      | issue controlled substance prescriptions, the registrant(s) must designate at least two individuals to manage access control to the             |
| at least      | a two-factor authentication credential as provided in &#167;&#8201;1311.105. at least                                                           |
| at least      | controlled substances are current and in good standing. at least                                                                                |
| after         | authentication credential to satisfy the logical access controls. after                                                                         |
| within        | (a) The entity  within an institutional practitioner that conducts the identity proofing                                                        |
| after         | permissions for logical access controls into the application. after                                                                             |
| within        | it must be sent to a separate entity within the institutional practitioner that enters permissions for logical                                  |
| at least      | The institutional practitioner must authorize  at least  two individuals or a role filled by                                                    |
| at least      | The institutional practitioner must authorize  at least  two individuals or a role filled by                                                    |
| at least      | (c) The electronic prescription application must digitally sign  at least all information required under part 1306 of this                      |
| minimum       | Auditable events must, at a  minimum , include the following:                                                                                   |
| at least      | electronic prescription application must analyze the audit trail at least once every calendar day and generate an incident                      |
| within        | the electronic prescription application provider and the Administration within  one business day.                                               |
| after         | transmit the electronic prescription as soon as possible after  signature by the practitioner.                                                  |
| prior to      | electronic prescription if an original prescription was printed prior to  attempted transmission.                                               |
| before        | pharmacy application does the following accurately and consistently: before                                                                     |
| at least      | by part 1306 of this chapter must be at least  FIPS 140-2 Security Level 1 validated.                                                           |
| within        | application must have a time application that is within five minutes of the official National Institute of                                      |
| within        | (14) The pharmacy application must record  within each audit record the following information: (i) The                                          |
| at least      | application must retain all archived records electronically for at least two years from the date of their receipt                               |
| prior to      | the pharmacy must digitally sign the prescription immediately prior to  transmission to the pharmacy.                                           |
| minimum       | The auditable events must, at a  minimum , include the following: (1) Attempted unauthorized access                                             |
| at least      | The pharmacy application must analyze the audit trail at least once every calendar day and generate an incident                                 |
| within        | application service provider, if applicable, and the Administration within  one business day.                                                   |
| before        | create, sign, transmit, or process controlled substance prescriptions. before                                                                   |
| before        | create, sign, transmit, or process controlled substance prescriptions. before                                                                   |
| within        | other audits or certifications of the application completed within  the previous two years.                                                     |
| within        | The application provider must notify registrants  within five business days of the issuance of the                                              |
| within        | report and provide the report to the Administration within  one business day of issuance.                                                       |
| no later than | use the application as soon as feasible, but no later than five business days after discovery, that the application                             |
| after         | feasible, but no later than five business days after discovery, that the application should not be used                                         |
| before        | must indicate that the updates must be installed before the practitioner or pharmacy may use the application                                    |


## Duration

| Duration    | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 24.0 hour   | (e) The certificate holder must report the loss, theft, or compromise of the private key or the password, via a revocation request, to the Certification Authority within 24 hours of substantiation of the loss, theft, or compromise.                                                                                                                                                                                                                  |
| 45.0 day    | (b) The Certification Authority will notify each CSOS certificate holder 45 days in advance of the expiration of the certificate holder's CSOS digital certificate.                                                                                                                                                                                                                                                                                      |
| 6.0 hour    | (a) A registrant that grants power of attorney must report to the DEA Certification Authority within 6 hours of either of the following (advance notice may be provided, where applicable):                                                                                                                                                                                                                                                              |
|             |             (1) The person with power of attorney has left the employ of the institution.                                                                                                                                                                                                                                                                                                                                                                |
| 10.0 minute | (5) The system must set a 10-minute inactivity time period after which the certificate holder must reauthenticate the password to access the private key.                                                                                                                                                                                                                                                                                                |
| 5 minute    | (8) The system must have a time system that is within five minutes of the official National Institute of Standards and Technology time source.                                                                                                                                                                                                                                                                                                           |
| 5 minute    | (8) The system must have a time system that is within five minutes of the official National Institute of Standards and Technology time source.                                                                                                                                                                                                                                                                                                           |
| 2 year      | The system developer must retain the most recent audit results and retain the results of any other audits of the software completed within the previous two years.                                                                                                                                                                                                                                                                                       |
| 2 year      | (a) A supplier and purchaser must maintain records of CSOS electronic orders and any linked records for two years.                                                                                                                                                                                                                                                                                                                                       |
| 1 day       | (b) The practitioner must notify the individuals designated under &#167;&#8201;1311.125 or &#167;&#8201;1311.130 within one business day of discovery that the hard token has been lost, stolen, or compromised or the authentication protocol has been otherwise compromised.                                                                                                                                                                           |
| 1 day       | (j) The practitioner must notify both the individuals designated under &#167;&#8201;1311.125 or &#167;&#8201;1311.130 and the Administration within one business day of discovery that one or more prescriptions that were issued under a DEA registration held by that practitioner were prescriptions the practitioner had not signed or were not consistent with the prescriptions he signed.                                                         |
| 5 minute    | (8) The electronic prescription application must have a time application that is within five minutes of the official National Institute of Standards and Technology time source.                                                                                                                                                                                                                                                                         |
| 7 day       | (27) The electronic prescription application must do the following:                                                                                                                                                                                                                                                                                                                                                                                      |
|             |             (i) Generate a log of all controlled substance prescriptions issued by a practitioner during the previous calendar month and provide the log to the practitioner no later than seven calendar days after that month.                                                                                                                                                                                                                         |
| 2 year      | Prescription information available from which to generate the log must span at least the previous two years.                                                                                                                                                                                                                                                                                                                                             |
| 2 year      | (28) Where the electronic prescription application is required by this part to archive or otherwise maintain records, it must retain such records electronically for two years from the date of the record's creation and comply with all other requirements of &#167;&#8201;1311.305.                                                                                                                                                                   |
| 1 day       | Any such incidents must be reported to the electronic prescription application provider and the Administration within one business day.                                                                                                                                                                                                                                                                                                                  |
| 5 minute    | (v) The pharmacy application must have a time application that is within five minutes of the official National Institute of Standards and Technology time source.                                                                                                                                                                                                                                                                                        |
| 2 year      | (18) The pharmacy application must retain all archived records electronically for at least two years from the date of their receipt or creation and comply with all other requirements of &#167;&#8201;1311.305.                                                                                                                                                                                                                                         |
| 1 day       | Any such incidents must be reported to the pharmacy application service provider, if applicable, and the Administration within one business day.                                                                                                                                                                                                                                                                                                         |
| 2 year      | (2) Whenever a functionality related to controlled substance prescription requirements is altered or every two years, whichever occurs first.                                                                                                                                                                                                                                                                                                            |
| 2 year      | (2) Whenever a functionality related to controlled substance prescription requirements is altered or every two years, whichever occurs first.                                                                                                                                                                                                                                                                                                            |
| 2 year      | The electronic prescription or pharmacy application provider must retain the most recent audit or certification results and retain the results of any other audits or certifications of the application completed within the previous two years.                                                                                                                                                                                                         |
| 5 day       | The application provider must notify registrants within five business days of the issuance of the audit or certification report that they should not use the application for controlled substance prescriptions.                                                                                                                                                                                                                                         |
| 1 day       | The application provider must also notify the Administration of the adverse audit or certification report and provide the report to the Administration within one business day of issuance.                                                                                                                                                                                                                                                              |
| 5 day       | (a) If an application provider identifies or is made aware of any issue with its application that make the application non-compliant with the requirements of this part, the application provider must notify practitioners or pharmacies that use the application as soon as feasible, but no later than five business days after discovery, that the application should not be used to issue or process electronic controlled substance prescriptions. |
| 2 year      | (b) Records required by this subpart must be maintained electronically for two years from the date of their creation or receipt.                                                                                                                                                                                                                                                                                                                         |


## Condition

| Condition     | Context                                                                                                                                         |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------------------|
| if            | any technology to sign and electronically transmit orders if the technology provides all of the following: (1)                                  |
| if            | any technology to sign and electronically transmit orders if the technology provides all of the following: (1)                                  |
| when          | signs orders only for that subset of schedules. when                                                                                            |
| when          | Even  when an individual registrant, i.e., an individual practitioner, is                                                                       |
| if            | If a designated coordinator changes, the Cert if ication Authority must be not                                                                  |
| if            | (2) A copy of each current DEA Cert if icate of Registration (DEA form 223) for each                                                            |
| if            | of the power of attorney from the registrant, if  applicable.                                                                                   |
| when          | channels, and information on how to use them. when                                                                                              |
| when          | pair and obtain a new CSOS digital certificate when  the registrant's DEA registration expires or                                               |
| if            | (c) If a CSOS cert if icate holder applies for a renewal before the                                                                             |
| if            | (d) If a CSOS cert if icate expires before the holder applies for a                                                                             |
| where         | of the following (advance notice may be provided, where applicable): (1) The person with power of attorney                                      |
| until         | recipient may cache Certificate Revocation Lists for use until  they expire.                                                                    |
| provided that | any system to write, track, or maintain orders provided that the system has been enabled to process digitally                                   |
| when          | (6) For software implementations,  when the signing module is deactivated, the system must                                                      |
| if            | create a report in the format DEA spec if ies, as provided in &#167;&#8201;1305.29 of this chapter.                                             |
| if            | II, III, IV, or V controlled substance electronically if all of the following conditions are met: (1)                                           |
| if            | of this subpart is not a valid prescription if any of the functions required under this subpart                                                 |
| when          | the functions required under this subpart were disabled when the prescription was indicated as ready for signature                              |
| if            | may process electronic prescriptions for controlled substances only if all of the following conditions are met: (1)                             |
| where         | must retain sole possession of the hard token, where applicable, and must not share the password or                                             |
| if            | (c) If the practitioner is not if ied by an intermediary or pharmacy that an                                                                    |
| if            | (e) If the third-party auditor or cert if ication organization has found that an electronic prescription                                        |
| subject to    | transmit electronic prescriptions for controlled substances that are subject to  the additional information requirements.                       |
| if            | to sign and transmit electronic controlled substance prescriptions if any of the functions of the application required                          |
| if            | (g) If an electronic prescription application provider not if ies an individual practitioner that a third-party audit                           |
| if            | (h) If an electronic prescription application provider not if ies an institutional practitioner that a third-party audit                        |
| until         | the application to issue electronic controlled substance prescriptions until it is notified that the application is again                       |
| when          | (k) The practitioner has the same responsibilities  when issuing prescriptions for controlled substances via electronic means                   |
| when          | (k) The practitioner has the same responsibilities  when issuing prescriptions for controlled substances via electronic means                   |
| if            | in the authentication protocol is a biometric, or if the practitioner has a hard token that is                                                  |
| where         | the individual practitioner's State authorization to practice and, where applicable, State authorization to prescribe controlled substances, is |
| if            | of Veterans Affairs pursuant to 38 U.S.C. 7401-7408. if                                                                                         |
| if            | controlled substances under the registration of such facility. if                                                                               |
| when          | imposes on entities that serve as trusted agents. when                                                                                          |
| if            | in &#167;&#8201;1311.08, for cryptographic modules or one-time-password devices. if                                                             |
| if            | subsystem must comply with the requirements of &#167;&#8201;1311.116. if                                                                        |
| if            | &#167;&#8201;1311.115, it must comply with the following requirements. if                                                                       |
| if            | biometric subsystem must conform to Personal Identity Ver if ication authentication biometric acquisition spec                                  |
| where         | uses to issue electronic prescriptions for controlled substances, where the computer or PDA is located in a                                     |
| when          | data or templates), match results, and/or non-match results when  authentication is not local.                                                  |
| unless        | individual to be assigned the role of registrant unless that individual is linked to at least one                                               |
| if            | registration number to be included on the prescription. if                                                                                      |
| if            | (v) The number of refills authorized,  if applicable, for prescriptions for Schedule III, IV, and                                               |
| where         | displayed along with the statement required by &#167;&#8201;1311.140(a)(3). where                                                               |
| when          | application must time and date stamp the prescription when  the signing function is used.                                                       |
| when          | chapter and electronically archive the digitally signed record. when                                                                            |
| when          | (iv) For software implementations,  when the signing module is deactivated, the application must                                                |
| unless        | the prescription was signed by the prescribing practitioner. unless                                                                             |
| unless        | application must not transmit a controlled substance prescription unless the signing function described in &#167;&#8201;1311.140(a)(4) has been |
| if            | allow printing of a prescription after transmission only if the printed prescription is clearly labeled as a                                    |
| if            | prescription application may allow printing of prescription information if  clearly labeled as being for informational purposes.                |
| if            | the electronic prescription application may print the prescription. if                                                                          |
| where         | The identity of the person taking the action, where  applicable.                                                                                |
| where         | and comply with all other requirements of &#167;&#8201;1311.305. where                                                                          |
| where         | (a) At each registered location  where one or more individual practitioners wish to use                                                         |
| where         | DEA registration and State authorization(s) to practice and, where applicable, State authorization(s) to dispense controlled substances of      |
| unless        | (2) The individual practitioner's DEA registration expires,  unless  the registration has been renewed.                                         |
| when          | authorized to use the electronic prescription application (e.g., when  the individual practitioner leaves the practice).                        |
| where         | (2) The institutional practitioner's or,  where applicable, individual practitioner's DEA registration expires, unless the                      |
| unless        | or, where applicable, individual practitioner's DEA registration expires, unless  the registration has been renewed.                            |
| where         | (3) The institutional practitioner's or,  where applicable, individual practitioner's DEA registration is terminated, revoked,                  |
| when          | use the institutional practitioner's electronic prescription application (e.g., when the individual practitioner is no longer associated with   |
| provided that | to enter data for a controlled substance prescription, provided that only the registrant may sign the prescription in                           |
| if            | with the requirements of &#167;&#8201;1301.12 of this chapter. if                                                                               |
| if            | the supervisor and who is the prescribing practitioner. if                                                                                      |
| if            | the electronic prescription application must check the cert if icate revocation list of the cert                                                |
| until         | The certificate revocation list may be cached  until the certification authority issues a new certificate revocation                            |
| when          | sign the prescription using the application's private key. when                                                                                 |
| where         | the electronic prescription application, or successful unauthorized access where  the determination of such is feasible.                        |
| where         | any information or records required by this part where  the determination of such is feasible.                                                  |
| as soon as    | electronic prescription application must transmit the electronic prescription as soon as  possible after signature by the practitioner.         |
| if            | print a prescription that has been transmitted only if  an intermediary or the designated pharmacy not                                          |
| if            | application may print copies of the transmitted prescription if they are clearly labeled: &#8220;Copy only&#8212;not valid for                  |
| if            | application may print copies of the transmitted prescription if they are clearly labeled: &#8220;Copy only&#8212;not valid for                  |
| if            | not allow the transmission of an electronic prescription if an original prescription was printed prior to attempted                             |
| where         | the practitioner's digital signature, as provided in &#167;&#8201;1311.210(c), where  applicable.                                               |
| if            | (b) If the third-party auditor or cert if ication organization has found that a pharmacy application                                            |
| subject to    | process electronic prescriptions for controlled substances that are subject to  the additional information requirements.                        |
| if            | (c) If a pharmacy application provider not if ies a pharmacy that a third-party audit or                                                        |
| until         | use the application to process controlled substance prescriptions until it is notified that the application is again                            |
| when          | the pharmacist must make the same notation electronically when filling an electronic prescription and retain the annotation                     |
| if            | pharmacist to make a notation on the prescription if the prescription were a paper prescription, the pharmacist                                 |
| when          | the pharmacist must make the same notation electronically when filling an electronic prescription and retain the annotation                     |
| when          | version was not received and the prescription dispensed. when                                                                                   |
| when          | determine whether the prescription was received and dispensed. when                                                                             |
| when          | (iv) For software implementations,  when the signing module is deactivated, the pharmacy application                                            |
| if            | signature, the pharmacy application must either: (i) Ver if y that the practitioner signed the prescription by                                  |
| where         | The identity of the person taking the action, where  applicable.                                                                                |
| if            | forward the digitally signed copy to the pharmacy. if                                                                                           |
| if            | pharmacy application must do the following: (1) Ver if y the digital signature as provided in FIPS                                              |
| until         | The pharmacy may cache the CRL  until  it expires.                                                                                              |
| where         | or successful unauthorized access to the pharmacy application where  the determination of such is feasible.                                     |
| where         | any information or records required by this part where  the determination of such is feasible.                                                  |
| if            | be reported to the pharmacy application service provider, if  applicable, and the Administration within one business day.                       |
| if            | (e) If a cert if ying organization whose cert                                                                                                   |
| provided that | of paragraphs (b) through (d) of this section, provided that the certification that determines that the application meets                       |
| if            | in paragraphs (h) and (i) of this section, if  the third-party auditor or cert                                                                  |
| if            | electronic prescription applications, the third-party auditor or cert if ication organization must make the following determinations: (1)       |
| if            | electronic prescription applications, the third-party auditor or cert if ication organization must make the following determinations: (1)       |
| if            | stored, and transmitted, the third-party auditor or cert if ication organization must indicate that the application has                         |
| if            | For pharmacy applications, the third-party auditor or cert if ication organization must make the following determinations: (1)                  |
| if            | practitioner's digital signature, the third-party auditor or cert if ication organization must indicate that the application does               |
| if            | practitioner's digital signature, the third-party auditor or cert if ication organization must indicate that the application does               |
| if            | stored, and displayed, the third-party auditor or cert if ication organization must indicate that the application has                           |
| if            | (a) If an application provider ident if ies or is made aware of any issue                                                                       |
| as soon as    | notify practitioners or pharmacies that use the application as soon as feasible, but no later than five business days                           |
| when          | to issue or process electronic controlled substance prescriptions. when                                                                         |
| if            | related to that prescription must be retained electronically. if                                                                                |
| if            | prescription application or an electronic pharmacy application or if a registrant ceases to use an application service                          |
| if            | prescription application or an electronic pharmacy application or if a registrant ceases to use an application service                          |
| subject to    | the application service provider must transfer any records subject to this part to the registrant in a format                                   |
| if            | retrieved, displayed, and printed in a readable format. if                                                                                      |
| subject to    | providers, the registrant must ensure that any records subject to this part are migrated to the new application                                 |
| if            | retrieved, displayed, and printed in a readable format. if                                                                                      |


## Entities

| Entities         | Context                                                                                                             |
|:-----------------|:--------------------------------------------------------------------------------------------------------------------|
| Food             | Food  and Drugs.                                                                                                    |
| Scope            | Scope .                                                                                                             |
| Burr, W.et       | 2008 (NIST SP 800-63-1); Burr, W. et al. Burr, W.et                                                                 |
| Eligibility      | Eligibility  to obtain a CSOS digital certificate.                                                                  |
| Registration     | A copy of each current DEA Certificate of Registration (DEA form 223) for each registered location for              |
| Practitioner     | Practitioner  responsibilities.                                                                                     |
| Failure          | Failure by the practitioner to secure the hard token,                                                               |
| Veterans Affairs | facility that is operated by the Department of Veterans Affairs , confirm that the individual practitioner has been |
| Veterans Affairs | facility that is operated by the Department of Veterans Affairs , confirm that the individual practitioner has been |
| Failure          | Failure to meet this obligation may result in remedial                                                              |
| Test             | (2)  Test  data are sequestered.                                                                                    |
| Electronic       | Electronic  prescription application requirements.                                                                  |
| Pharmacy         | Pharmacy  responsibilities.                                                                                         |
| Pharmacy         | Pharmacy  application requirements.                                                                                 |
| Internal         | Internal  audit trail.                                                                                              |
| Application      | Application  provider requirementsâ€”Third-party audits or certifications.                                            |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2002-12-03 | The following standards are incorporated by reference:                                                                                                                                                                                                                                                                                                                                                                               |
|            |             (1) Federal Information Processing Standard Publication (FIPS PUB) 140-2, Change Notices (12-03-2002), Security Requirements for Cryptographic Modules, May 25, 2001 (FIPS 140-2) including Annexes A through D; incorporation by reference approved for &#167;&#167;&#8201;1311.30(b), 1311.55(b), 1311.115(b), 1311.120(b), 1311.205(b).                                                                               |
| 2001-05-25 | The following standards are incorporated by reference:                                                                                                                                                                                                                                                                                                                                                                               |
|            |             (1) Federal Information Processing Standard Publication (FIPS PUB) 140-2, Change Notices (12-03-2002), Security Requirements for Cryptographic Modules, May 25, 2001 (FIPS 140-2) including Annexes A through D; incorporation by reference approved for &#167;&#167;&#8201;1311.30(b), 1311.55(b), 1311.115(b), 1311.120(b), 1311.205(b).                                                                               |
| 2004-09-23 | (i) Annex A: Approved Security Functions for FIPS PUB 140-2, Security Requirements for Cryptographic Modules, September 23, 2004.                                                                                                                                                                                                                                                                                                    |
| 2004-11-04 | (ii) Annex B: Approved Protection Profiles for FIPS PUB 140-2, Security Requirements for Cryptographic Modules, November 4, 2004.                                                                                                                                                                                                                                                                                                    |
| 2005-01-31 | (iii) Annex C: Approved Random Number Generators for FIPS PUB 140-2, Security Requirements for Cryptographic Modules, January 31, 2005.                                                                                                                                                                                                                                                                                              |
| 2004-02-23 | (iv) Annex D: Approved Key Establishment Techniques for FIPS PUB 140-2, Security Requirements for Cryptographic Modules, February 23, 2004.                                                                                                                                                                                                                                                                                          |
| 2002-08-01 | (2) Federal Information Processing Standard Publication (FIPS PUB) 180-2, Secure Hash Standard, August 1, 2002, as amended by change notice 1, February 25, 2004 (FIPS 180-2); incorporation by reference approved for &#167;&#167;&#8201;1311.30(b) and 1311.55(b).                                                                                                                                                                 |
| 2025-02-01 | (2) Federal Information Processing Standard Publication (FIPS PUB) 180-2, Secure Hash Standard, August 1, 2002, as amended by change notice 1, February 25, 2004 (FIPS 180-2); incorporation by reference approved for &#167;&#167;&#8201;1311.30(b) and 1311.55(b).                                                                                                                                                                 |
| 2008-10-01 | (3) Federal Information Processing Standard Publication (FIPS PUB) 180-3, Secure Hash Standard (SHS), October 2008 (FIPS 180-3); incorporation by reference approved for &#167;&#167;&#8201;1311.120(b) and 1311.205(b).                                                                                                                                                                                                             |
| 2000-01-27 | (4) Federal Information Processing Standard Publication (FIPS PUB) 186-2, Digital Signature Standard, January 27, 2000, as amended by Change Notice 1, October 5, 2001 (FIPS 186-2); incorporation by reference approved for &#167;&#167;&#8201;1311.30(b) and 1311.55(b).                                                                                                                                                           |
| 2005-10-01 | (4) Federal Information Processing Standard Publication (FIPS PUB) 186-2, Digital Signature Standard, January 27, 2000, as amended by Change Notice 1, October 5, 2001 (FIPS 186-2); incorporation by reference approved for &#167;&#167;&#8201;1311.30(b) and 1311.55(b).                                                                                                                                                           |
| 2009-06-01 | (5) Federal Information Processing Standard Publication (FIPS PUB) 186-3, Digital Signature Standard (DSS), June 2009 (FIPS 186-3); incorporation by reference approved for &#167;&#167;&#8201;1311.120(b), 1311.205(b), and 1311.210(c).                                                                                                                                                                                            |
| 2008-12-08 | (6) Draft NIST Special Publication 800-63-1, Electronic Authentication Guideline, December 8, 2008 (NIST SP 800-63-1); Burr, W. et al.                                                                                                                                                                                                                                                                                               |
| 2007-01-01 | (7) NIST Special Publication 800-76-1, Biometric Data Specification for Personal Identity Verification, January 2007 (NIST SP 800-76-1); Wilson, C. et al.                                                                                                                                                                                                                                                                           |
| 2018-09-01 | (5) The system must validate that the DEA registration number contained in the body of the order corresponds to the registration number associated with the specific certificate by separately generating the hash value of the registration number and certificate subject distinguished name serial number and comparing that hash value to the hash value contained in the certificate extension for the DEA registration number. |


